Cart
sales@molnova.com
SC-806
CAS No. 216505-89-4
SC-806( SC 806 | SC806 )
Catalog No. M13454 CAS No. 216505-89-4
A potent, orally active p38 MAPK inhibitor with IC50 of 50 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSC-806
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, orally active p38 MAPK inhibitor with IC50 of 50 nM.
-
DescriptionA potent, orally active p38 MAPK inhibitor with IC50 of 50 nM, significantly decreases incidence of arthritis in mouse collagen-induced arthritis.
-
In Vitro——
-
In Vivo——
-
SynonymsSC 806 | SC806
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptorp38 MAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number216505-89-4
-
Formula Weight353.854
-
Molecular FormulaC19H20ClN5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name1-(5-(4-chlorophenyl)-4-(4-pyridinyl)-1H-pyrazol-3-yl)-4-methylpiperazine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Graneto MJ, et al. J Med Chem. 2007 Nov 15;50(23):5712-9.
molnova catalog
related products
-
PH797804
PH-797804 is a novel pyridinone inhibitor of p38α with IC50 of 26 nM in a cell-free assay; 4-fold more selective versus p38β and does not inhibit JNK2. Phase 2.
-
Darizmetinib
Darizmetinib (HRX215, HRX-0215) is an MKK4 inhibitor. Inhibition of MKK4 leads to enhancement of the MKK7 and JNK1 signaling pathways, thereby activating the transcription factors ATF2 and ELK1, promoting cell proliferation and liver regeneration.
-
BI-2865
BI-2865 is a none-covalent pan-KRAS Inhibitor. BI-2865 binds to WT, G12C, G12D, G12V and G13D mutant KRAS with KDs of 6.9, 4.5, 32, 26, 4.3 nM respectively.
